Search Count: 77
 |
Sars-Cov-2 Mpro In Complex With Compound 12D Inhibitor
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.81 Å Release Date: 2025-04-16 Classification: VIRAL PROTEIN, Hydrolase Ligands: GLY, VAL, THR, PHE, A1ALW |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-04-16
Ligands: GLY, VAL, THR, PHE, A1ALW
 |
Sars-Cov-2 Mpro In Complex With Compound 6C Inhibitor
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.78 Å Release Date: 2025-04-16 Classification: VIRAL PROTEIN, Hydrolase Ligands: A1ALF |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-04-16
Ligands: A1ALF
 |
Sars-Cov-2 Mpro In Complex With Compound 6B Inhibitor
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2025-04-16 Classification: VIRAL PROTEIN, Hydrolase Ligands: A1ALL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-04-16
Ligands: A1ALL
 |
Sars-Cov-2 Mpro In Complex With Compound 6D Inhibitor
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2025-04-16 Classification: VIRAL PROTEIN, Hydrolase Ligands: A1ALG |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-04-16
Ligands: A1ALG
 |
Sars-Cov-2 Mpro In Complex With Compound 6F Inhibitor
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.57 Å Release Date: 2025-04-16 Classification: VIRAL PROTEIN, Hydrolase Ligands: A1ALH |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-04-16
Ligands: A1ALH
 |
Sars-Cov-2 Mpro In Complex With Compound 6H Inhibitor
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2025-04-16 Classification: VIRAL PROTEIN, Hydrolase Ligands: A1ALK, EDO |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-04-16
Ligands: A1ALK, EDO
 |
Sars-Cov-2 Mpro In Complex With Compound 6J Inhibitor
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.46 Å Release Date: 2025-04-16 Classification: VIRAL PROTEIN, Hydrolase Ligands: A1ALD |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-04-16
Ligands: A1ALD
 |
Sars-Cov-2 Mpro In Complex With Compound 6K Inhibitor
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.31 Å Release Date: 2025-04-16 Classification: VIRAL PROTEIN, Hydrolase Ligands: A1ALM |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-04-16
Ligands: A1ALM
 |
Sars-Cov-2 Mpro In Complex With Compound 6L Inhibitor
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2025-04-16 Classification: VIRAL PROTEIN, Hydrolase Ligands: A1ALN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-04-16
Ligands: A1ALN
 |
Sars-Cov-2 Mpro In Complex With Compound 18B Inhibitor
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2025-04-16 Classification: VIRAL PROTEIN, Hydrolase Ligands: A1ALU |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-04-16
Ligands: A1ALU
 |
Sars-Cov-2 Mpro In Complex With Compound 18D Inhibitor
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.62 Å Release Date: 2025-04-16 Classification: VIRAL PROTEIN, Hydrolase Ligands: A1ALV |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-04-16
Ligands: A1ALV
 |
Sars-Cov-2 Mpro In Complex With Compound 18R Inhibitor
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.08 Å Release Date: 2025-04-16 Classification: VIRAL PROTEIN, Hydrolase Ligands: A1ALX |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-04-16
Ligands: A1ALX
 |
Crystal Structure Matriptase (C731S) In Complex With Inhibitor Mm1132-2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.35 Å Release Date: 2024-07-10 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: SO4, CL, GOL, YIL |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-07-10
Ligands: SO4, CL, GOL, YIL
 |
Sulfonated Calpeptin Is A Promising Drug Candidate Against Sars-Cov-2 Infections
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2023-09-27 Classification: HYDROLASE Ligands: CA |
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2023-09-27
Ligands: CA
 |
Polymorphism In Sars-Cov-2 Nsp5 Main Protease Reveals Differences In Cleavage Of Viral And Host Substrates
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.60 Å Release Date: 2023-05-17 Classification: HYDROLASE |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-05-17
 |
Polymorphism In Sars-Cov-2 Nsp5 Main Protease Reveals Differences In Cleavage Of Viral And Host Substrates
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2023-05-03 Classification: VIRAL PROTEIN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-05-03
 |
Polymorphism In Sars-Cov-2 Nsp5 Main Protease Reveals Differences In Cleavage Of Viral And Host Substrates
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2023-05-03 Classification: VIRAL PROTEIN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-05-03
 |
Polymorphism In Sars-Cov-2 Nsp5 Main Protease Reveals Differences In Cleavage Of Viral And Host Substrates
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.11 Å Release Date: 2023-05-03 Classification: VIRAL PROTEIN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-05-03
 |
Polymorphism In Sars-Cov-2 Nsp5 Main Protease Reveals Differences In Cleavage Of Viral And Host Substrates
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2023-05-03 Classification: VIRAL PROTEIN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-05-03
 |
Polymorphism In Sars-Cov-2 Nsp5 Main Protease Reveals Differences In Cleavage Of Viral And Host Substrates
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2023-05-03 Classification: VIRAL PROTEIN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-05-03